Skip to content
10-Q

Quarterly Report

Korro Bio, Inc. KRRO

0001193125-26-210303

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 4, 2026 14.42M sh
Shares Diluted Q1 2026 · Mar 31, 2026 11.6M sh
Shares Diluted Q1 2026 · Mar 31, 2025 9.38M sh
Capex Q1 2026 · Mar 31, 2026 $21K
Capex Q1 2026 · Mar 31, 2025 $119K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$16.07M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$24.45M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $61.7M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $21.82M
Stockholders Equity Q1 2026 · Mar 31, 2026 $119.63M
Stockholders Equity Q1 2026 · Dec 31, 2025 $51.44M
Stockholders Equity Q1 2026 · Mar 31, 2025 $138.96M
Stockholders Equity Q1 2026 · Dec 31, 2024 $160.42M
Current Liabilities Q1 2026 · Mar 31, 2026 $14.79M
Current Liabilities Q1 2026 · Dec 31, 2025 $11.94M
Total Liabilities Q1 2026 · Mar 31, 2026 $63.99M
Total Liabilities Q1 2026 · Dec 31, 2025 $62.07M
Current Assets Q1 2026 · Mar 31, 2026 $120.16M
Current Assets Q1 2026 · Dec 31, 2025 $82.37M
Total Assets Q1 2026 · Mar 31, 2026 $183.62M
Total Assets Q1 2026 · Dec 31, 2025 $113.51M
Eps Diluted Q1 2026 · Mar 31, 2026 −$1.69
Eps Diluted Q1 2026 · Mar 31, 2025 −$2.49
Eps Basic Q1 2026 · Mar 31, 2026 −$1.69
Eps Basic Q1 2026 · Mar 31, 2025 −$2.49
Sga Expense Q1 2026 · Mar 31, 2026 $7.49M
Sga Expense Q1 2026 · Mar 31, 2025 $7.83M
Rd Expense Q1 2026 · Mar 31, 2026 $12.95M
Rd Expense Q1 2026 · Mar 31, 2025 $19.74M
Net Income Q1 2026 · Mar 31, 2026 −$19.63M
Net Income Q1 2026 · Mar 31, 2025 −$23.39M
Operating Income Q1 2026 · Mar 31, 2026 −$20.44M
Operating Income Q1 2026 · Mar 31, 2025 −$25.02M